ArticleCancer cell2023

Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancer.

Brigette B Y Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.